OBJECTIVE: To assess the susceptibility of Trypanosoma cruzi strains from Amazon to benznidazole. METHODS: We studied 23 strains of T. cruzi obtained from humans in the acute phase of Chagas disease, triatomines and marsupials in the state of Amazonas and from chronic patients and triatomines in the state of Paraná, Brazil. The strains were classified as TcI (6), TcII (4) and TcIV (13). For each strain, 20 Swiss mice were inoculated: 10 were treated orally with benznidazole 100 mg/kg/day (TBZ group) for 20 consecutive days and 10 comprised the untreated control group (NT). Fresh blood examination, haemoculture (HC), PCR, and ELISA were used to monitor the cure. RESULTS: The overall cure rate was 60.5% (109/180 mice) and varied widely among strains. The strains were classified as resistant, partially resistant or susceptible to benznidazole, irrespective of discrete typing units (DTUs), geographical origin or host. However, the TcI strains from Amazonas were significantly (P = 0.028) more sensitive to benznidazole than the TcI strains from Paraná. The number of parasitological, molecular and serological parameters that were significantly reduced by benznidazole treatment also varied among the DTUs; the TBZ group of mice inoculated with TcIV strains showed more reductions (8/9) than those with TcI and TcII strains. CONCLUSIONS: Benznidazole resistance was observed among natural populations of the parasite in the Amazon, even in those never exposed to the drug.
OBJECTIVE: To assess the susceptibility of Trypanosoma cruzi strains from Amazon to benznidazole. METHODS: We studied 23 strains of T. cruzi obtained from humans in the acute phase of Chagas disease, triatomines and marsupials in the state of Amazonas and from chronic patients and triatomines in the state of Paraná, Brazil. The strains were classified as TcI (6), TcII (4) and TcIV (13). For each strain, 20 Swiss mice were inoculated: 10 were treated orally with benznidazole 100 mg/kg/day (TBZ group) for 20 consecutive days and 10 comprised the untreated control group (NT). Fresh blood examination, haemoculture (HC), PCR, and ELISA were used to monitor the cure. RESULTS: The overall cure rate was 60.5% (109/180 mice) and varied widely among strains. The strains were classified as resistant, partially resistant or susceptible to benznidazole, irrespective of discrete typing units (DTUs), geographical origin or host. However, the TcI strains from Amazonas were significantly (P = 0.028) more sensitive to benznidazole than the TcI strains from Paraná. The number of parasitological, molecular and serological parameters that were significantly reduced by benznidazole treatment also varied among the DTUs; the TBZ group of mice inoculated with TcIV strains showed more reductions (8/9) than those with TcI and TcII strains. CONCLUSIONS:Benznidazole resistance was observed among natural populations of the parasite in the Amazon, even in those never exposed to the drug.
Authors: Ana Paula Gruendling; Miyoko Massago; Ana Paula M Teston; Wuelton M Monteiro; Edilson N Kaneshima; Silvana M Araújo; Mônica L Gomes; Maria das Graças V Barbosa; Max Jean O Toledo Journal: Am J Trop Med Hyg Date: 2015-05-04 Impact factor: 2.345
Authors: Christian Olivo Freites; Hendrik Sy; Amal Gharamti; Nelson I Agudelo Higuita; Carlos Franco-Paredes; José Antonio Suárez; Andrés F Henao-Martínez Journal: Curr Heart Fail Rep Date: 2022-08-11
Authors: Silvane Maria Fonseca Murta; Laila Alves Nahum; Jéssica Hickson; Lucas Felipe Almeida Athayde; Thainá Godinho Miranda; Policarpo Ademar Sales Junior; Anderson Coqueiro Dos Santos; Lúcia Maria da Cunha Galvão; Antônia Cláudia Jácome da Câmara; Daniella Castanheira Bartholomeu; Rita de Cássia Moreira de Souza Journal: Parasit Vectors Date: 2022-06-06 Impact factor: 4.047
Authors: Ana Paula de Abreu; Hevillyn Fernanda Lucas da Silva; Marcella Paula Mansano Sarto; Giullia Ferreira Iunklaus; João Vitor Trovo; Nilma de Souza Fernandes; Ana Paula Margioto Teston; Max Jean de Ornelas Toledo Journal: Parasit Vectors Date: 2022-06-30 Impact factor: 4.047
Authors: Robson Xavier Faria; Daniel Tadeu Gomes Gonzaga; Paulo Anastácio Furtado Pacheco; André Luis Almeida Souza; Vitor Francisco Ferreira; Fernando de Carvalho da Silva Journal: J Bioenerg Biomembr Date: 2018-02-23 Impact factor: 2.945
Authors: Gabriele Sass; Roy T Madigan; Lydia-Marie Joubert; Adriana Bozzi; Nazish Sayed; Joseph C Wu; David A Stevens Journal: Am J Trop Med Hyg Date: 2019-08 Impact factor: 2.345
Authors: Carolina B Moraes; Miriam A Giardini; Hwayoung Kim; Caio H Franco; Adalberto M Araujo-Junior; Sergio Schenkman; Eric Chatelain; Lucio H Freitas-Junior Journal: Sci Rep Date: 2014-04-16 Impact factor: 4.379